Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunoprecise Antibodies Ltd (NQ: IPA )

1.700 +0.130 (+8.28%)
Streaming Delayed Price Updated: 3:59 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,464
Open 1.510
Bid (Size) 1.590 (1)
Ask (Size) 1.700 (10)
Prev. Close 1.570
Today's Range 1.510 - 1.750
52wk Range 1.136 - 5.900
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release Call
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery
Via ACCESSWIRE

Performance

YTD
-67.37%
-67.37%
1 Month
-19.81%
-19.81%
3 Month
-16.26%
-16.26%
6 Month
-45.61%
-45.61%
1 Year
-65.52%
-65.52%

More News

Read More
ImmunoPrecise's BioStrand® Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery
Via Benzinga
BioStrand® Unveils a Revolutionary Approach to Biological Sequence Retrieval: A Fusion of Natural Language Processing and Database Research
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Earnings Outlook For ImmunoPrecise Antibodies
Via Benzinga
ImmunoPrecise Antibodies's Earnings Outlook
Via Benzinga
EXCLUSIVE: Antibody-Discovery Platform Provider ImmunoPrecise's Subsidiary Highlights Approach to Biological Sequence Retrieval
Via Benzinga
IPA’s Subsidiary, BioStrand, Provides an Update on LENSai™
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
IPA Provides Update on Growth Strategy and Recent Share Price Movement
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Overcoming the Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data
Via ACCESSWIRE
Overcoming The Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological Data
Via Benzinga
How ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody Research
Via ACCESSWIRE
How ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody Research
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
ImmunoPrecise Antibodies Announces CFO Transition
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024 on September 14, 2023
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
IPA Announces Board Refreshment
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
IPA Responds to 13D Filing
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Antibodies Invites Investors and Stakeholders to Exclusive Interview with Market Radius Research
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2023
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
Earnings Scheduled For July 7, 2023
Via Benzinga
Costco, AZZ And 3 Stocks To Watch Heading Into Friday
Via Benzinga
Investor Sentiment Drops Following Economic Reports
Via Benzinga
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2023 on July 7th, 2023.
From ImmunoPrecise Antibodies Ltd.
Via Business Wire
“Convergence of AI and Biology: Companies at the Forefront of Transformative Innovations”:- IPA, MRKR, PRAX , RMED
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.